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Abstract
 .Phosphatidylinositol PI 3-kinase is known as one of the key molecules involved in the various biological events such as
vesicle trafficking, cytoskeletal rearrangements and cell survival. To clarify the molecular basis underlying these events, we
 .have tried to identify the proteins that can interact with phosphatidylinositol 3,4,5-trisphosphate PIP , the lipid product of3
PI3-kinase. Using a new PIP analogue, PIP -APB, we synthesized an affinity column for PIP binding proteins. This3 3 3
enabled us to purify and identify several PIP binding proteins such as Tec tyrosine kinase, Gap1m, and Akt, as the3
candidates for the downstream molecules of PI3-kinase. All of these proteins contain PH domains, possible binding sites for
phospholipids. Studies with various deletion mutants of Tec or Gap1m revealed that their PH domains are indeed the
binding sites for PIP . These results demonstrate that this PIP analogue binds various PIP binding proteins with high3 3 3
specificity and may be useful to elucidate the downstream mechanisms of PI3-kinases-mediated signaling pathways. q 1998
Elsevier Science B.V.
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1. Introduction
 .Phosphatidylinositol PI 3-kinase is one of the
important molecules involved in the signal transduc-
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w xtion for cell growth and differentiation 1,2 . There
are several types of PI3-kinases some of which are
activated by tyrosine kinases and some by het-
erotrimeric G proteins. The heterodimer type of PI3-
kinase may be activated by tyrosine kinases. This
 .type of PI3-kinase consists of 110 kD p110 and 85
 .kD p85 subunits which are the catalytic and regula-
w xtory subunits, respectively 2 . G-protein-activated
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ones may have different structures. PI3-kinase is
rapidly activated upon growth factor stimulation to
elevate the cellular level of its specific product, PI
 . w x3,4,5-trisphosphate PIP 1,3,4 . PIP subsequently3 3
undergoes dephosphorylation by a specific phos-
w xphatase to yield PI 3,4-P 3–6 . PIP as well as PI2 3
3,4-P may serve as second messengers. For instance,2
PIP or PI 3,4-P activate certain subtypes of atypical3 2
 . protein kinase C aPKC , Akt, and PDK1 PIP de-3
. w xpendent kinase 1 respectively 7–10 . Akt is the
cellular counterpart of v-Akt, an oncogene of a retro
virus, which is shown to be involved in the signal
transduction of apoptosis. Akt may be activated by PI
3,4-P . PDK1 is the enzyme that phosphorylate Akt2
to regulate its kinase activity. This one is shown to be
activated by PIP . These signaling pathways of pro-3
tein kinases are obviously important for cell re-
sponses, however, there still remain many PI3-
kinase-mediated responses that may not be explained
by the activation of these known cascades. Therefore,
it would be important for further understanding the
function of PI3-kinase in vivo, to characterize uniden-
tified PIP binding proteins. We and others have tried3
to search for the PIP binding proteins using various3
PIP analogue beads. We identified a PIP binding3 3
protein, PIP BP containing two pleckstrin homology3
 .PH domains and a sequence homologous to Arf-
w xGTPase activating protein by such an approach 11 .
However, these analogue beads, such as our IP -APB3
w xbeads 11 , contain only the head group of PIP3
which is identical to inositol 1,3,4,5-tetrakisphos-
 .phate IP . Therefore, we designed a novel PIP4 3
analogue containing a glycerol group as well as fatty
 .acid groups PIP -APB, see below to detect PIP3 3
binding proteins with higher specificity. In this study,
we demonstrate that this PIP analogue interacts with3
various PH-containing proteins such as Tec tyrosine
kinase and Gap1m and identified them as novel PIP3
binding proteins.
2. Materials and methods
2.1. Materials
 .Synthetic PIP distealoyl PIP was prepared as3 3
w xdescribed by Sawada et al. 12 . Phosphatidylserine
 . PS and PI were purchased from Avanti Alabaster,
.AL . D-myo-IP and PI 4,5-P were purchased from4 2
 .Dojindo Kumamoto, Japan and Boehringer
 .Mannheim Indianapolis, IN , respectively. The mi-
celles of PI, PI 4-P, PI 4,5-P , PIP were formed with2 3
PS as a carrier. They were mixed with PS at the ratio
of 1:10 in chloroform, dried up and then dissolved in
dimethylsulfoxide at the concentration of 2 mgrml.
The lipid solutions were added to a buffer 20 mM
Tris-HCl, pH 7.0, 150 mM NaCl, 1 mM EDTA, 1
.mM EGTA and mixed immediately to form mi-
celles.
( )2.2. Synthesis of PIP -APB PI 3,4,5-P analogue3 3
beads
The scheme of the synthetic procedure for PIP -3
APB is shown in Fig. 1. 4-Methoxybenzylation of
 .  .  .S - q -2,2-dimethyldioxolane-4-methanol 1 fol-
lowed by the acidic cleavage of acetal gave diol 2.
The primary and secondary hydroxyl groups were
successively acylated w ith N -C bz-4- 4-
.aminophenyl butyric acid-dicyclohexyl carbodiimide
 .DCC and acetic anhydride to give diester 3. Re-
 .moval of the 4-methoxybenzyl PMB group with
 .2,3-dichloro-5,6-dicyano-1,4-benzoquinone DDQ in
wet CH Cl gave alcohol 4. The amidite 5 was2 2
obtained by the coupling of 4 and benzyl
N, N, N X, N X-tetraisopropylphosphoramidite in the
presence of 1H-tetrazole. The appropriately protected
chiral inositol intermediate 6 was synthesized accord-
ing to the Prestwichs method from methyl a-D-gluco-
pyranoside through 9 steps in 26% overall yield
w x12–15 . The coupling of amidite 5 with inositol 6
followed by the oxidation with tertbutyl hydro-
 .peroxide TBHP in one pot gave a epimeric mixture
w xof 7 16,17 . Removal of the PMB groups with DDQ
in wet CH Cl gave triol 8. Phosphitylation of the2 2
resulting triol with dibenzyl N, N-diethylphos-
phoramidite followed by oxidation with TBHP in one
pot gave fully protected PIP -APB. Deprotection of3
 .  .all benzyl Bn and benzyloxymethyl BOM groups
of 6 was carried out by the hydrogenolysis over Pd
Black in t-BuOH in the presence of NaHCO .3
 .Affigel-10 100 ml:Bio-Rad was incubated with
 . PIP -APB 0.28 mg in the buffer 100 mM3
.HepesrNaOH pH 7.4, 80 mM CaCl at room tem-2
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Fig. 1. Synthesis of PIP -APB. The strategy of synthesis of the PIP analogue was shown. a, 4-methoxybenzyl chloride, t-BuOK, and3 3
 .  .t-BuOH; b, 50% acetic acid 2 steps, 87% ; c, N-Cbz-4- 4-aminophenyl butyric acid and DCC; d, acetic anhydride, pyridine, and
 .  . X X4-dimethylaminopyridine 2 steps, 71% ; e, DDQ and wet CH Cl 56% ; f, benzyl N, N, N , N -tetraisopropylphosphoramidite,2 2
 .1H-tetrazole, and CH Cl 97% ; g, 6, 1H-tetrazole, and CH Cl at room temperature, then TBHP from y788C to room temperature2 2 2 2
 .  .  .80% ; h, DDQ and wet CH Cl at room temperature 46% ; i, BnO PNEt , 1H-tetrazole, and CH Cl at room temperature, then2 2 2 2 2 2
 .  .TBHP from y788C to room temperature 72% ; j, H 50 psi , Pd black, NaHCO , and 85% t-BuOHrH O.2 3 2
perature for 24 h. After washing with water for 3
times, the PIP -APB beads were used in the follow-3
ing study.
2.3. Plasmids used in this study
Myc-tagged Gap1m cDNA was inserted into XbaI
w xsite of pEF-BOS 18 . The full length cDNA of
mouse Tec was subcloned into the pTagCMVneo or
the pSR a vector for the expression experiments of
wild type Tec protein. The cDNAs encoding the
 .  .  .amino acids 1-182 -TH , 1-243 -SH3 , 1-363 -SH2
w xof murine Tec type IV protein 19 were PCR-ampli-
w xfied and inserted into the pTagCMVneo vector 20 .
The cDNA which encoded the mouse Tec protein
 .lacking its PH domain DPH was generated by the
PCR-amplification of Tec cDNA with the oligo-
nucleotide primers 5-CCGGATCCGAGATGAT-
TAAATACCATCCTAAA-3 and 5-GGCCAGAAT-
.TCATCTTCCAAAAGT-3 , and was subcloned into
w xthe pSR a expression vector 19 . Construction of the
expression plasmid of Tec with an internal deletion
w xof the SH3 domain was described previously 21 .
2.4. Purification of PIP binding proteins by PIP -3 3
APB beads
 .The bovine brain or thymus 3.0 g was homoge-
nized in 20 ml of a homogenizing buffer 20 mM
Tris-HCl, pH 7.0, 150 mM NaCl, 1 mM EDTA, 1
mM EGTA, and 1 mM phenylmethylsulfonyl fluoride
w x.PMSF and cell debris was removed by the centrifu-
gation at 10 000=g for 10 min. The cytosolic frac-
tion of the lysates was obtained after the centrifuga-
tion at 100 000=g for 1 h, and 1 ml of the cytosolic
 .fraction was mixed with PIP -APB beads 7 ml at3
48C for 4 h. After washing the beads with the homog-
enizing buffer for 3 times, the proteins bound to the
w xbeads were eluted with a sample buffer 22 , sepa-
rated by SDS polyacrylamide gel electrophoresis
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 .PAGE , and visualized by silver staining or
immunoblotting.
2.5. Binding of Tec or Gap1m expressed in
mammalian cells to PIP -APB beads3
Subconfluent cultures of COS-7 cells cultured in
10 cm dishes were transfected with 1 mg of the
expression vectors carrying the cDNAs of Tec or
m w xGap1 by the DEAE dextran method 23 . After
incubation for 2 days, the cytosolic fraction of the
cells were prepared and proteins bound to the beads
were analyzed as described above. Sometimes, the
cells were lysed with NP-40 buffer 20 mM Tris-HCl
pH 7.0, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
.1% NP-40, and 1 mM PMSF , cleared by centrifuga-
tion, and the samples were incubated with PIP -APB3
beads. In some sets of experiments, the samples were
incubated with phospholipid micelles or IP for 1 h4
before the addition of PIP -APB beads to compete3
out the interaction with PIP -APB. The proteins bound3
to the beads were subjected to immunoblotting using
anti-Tec polyclonal antibody raised against Tec TH
and SH3 domain, anti-Gap1m antibody raised against
Fig. 2. PIP -APB can interact with more PIP binding proteins than IP -APB. Panel A. Cytosolic fraction of bovine brain was prepared3 3 3
 .  .  .and mixed with mock lane 1 , IP -APB lane 2 , and PIP -APB conjugated beads lane 3 . Proteins bound to the beads were separated by3 3
SDS-PAGE, and visualized by silver staining. The positions of molecular weight standards were indicated at the left. Panel B. Protein
bound to the PIP -APB was prepared from bovine brain as described in the text. Prior to mixing with the beads, lysates were incubated3
 .  .  .with PS micelles containing 12 mM PIP lane 3 , 12 mM PI4,5-P lane 4 , or none lane 2 . lane 1, a control without any competitor. In3 2
the presence of synthetic PIP , several proteins did not bind to the beads. Such proteins were indicated by arrows. Panel C. Structure of3
PIP analogues, IP -APB and PIP -APB.3 3 3
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Fig. 3. Identification of Gap1m as a PIP binding protein. Panel A. The cytosolic fraction of bovine brain was prepared and mixed with3
 .  .the beads conjugated with lane 2 and 3 , or without lane 1 PIP -APB. Prior to mixing with the beads, 4 mM PIP was added to the3 3
 .lysate lane 3 . Proteins bound to the beads were resolved by SDS-PAGE, transferred to a PVDF membrane, and immunostained with an
anti-Gap1m anti sera prepared by immunizing rabbits with GST-Gap1mPH. Panel B. The lysates of COS-7 cells transfected with the
m  .  .expression vector for Gap1 lanes 3–7 or the empty vector lanes 1 and 2 were prepared and mixed with the beads conjugated with
 .  .lanes 2, 4–7 or without lane 1 and 3 PIP -APB. For lanes 5–7, synthetic PIP was added to the lysate prior to mixing with the beads at3 3
the concentration indicated in the figure.
Fig. 4. Gap1m PH domain is the binding site for PIP . Panel A. Structures of Gap1m deletion mutants are shown. Panel B. Recombinant3
m Gap1 deletion mutants were purified as described in the text. Two mg of protein lane 2: GST-C2qGRD, lane 3: GST-C2, lane 4:
.GST-PH, lane 1: GST alone was mixed with PIP -APB and the protein bound to the beads was separated by SDS-PAGE, and stained3
with Coomassie blue. The arrow heads indicates the positions of the fusion proteins. The positions of molecular weight standards are
shown at the left. Panel C. Gap1m PH domain was mixed with PIP -APB beads. Prior to mixing with the beads, protein was incubated3
 .  .  .  .with 4 mM of PIP lane 2 , 4 mM of IP lane 3 , 20 mM of IP lane 4 , or without competitor lane 1 .3 4 4
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GST-Gap1mPH, or anti-myc monoclonal antibody.
The reacted antigens were visualized by the ECL
 .detection system Amersham, Arlington Heights, IL .
( )2.6. Preparation of glutathione-S-transferase GST -
fusion proteins
For the expression of Gap1m full length cDNA as
a fusion protein with glutathione-S-transferase,
m NcoI-EcoRI fragment of Gap1 cDNA GenBank
.accession number D30734 was inserted between
BamHI and EcoRI sites of pGEX-2T by using a
 X X Xsynthetic linker 5 -GATCCAC-3 and 5 -GTG-
X. m mGTAC-3 to yield pGEX-Gap1 . pGEX-Gap1 C2
.qGRD was produced by self-ligation of SacI di-
m m  .gested pGEX-Gap1 . pGEX-Gap1 C2 was con-
structed by inserting NcoI-HincII fragment of Gap1m
cDNA into NcoIrSmaI digested pGEX-Gap1m.
m .pGEX-Gap1 PH was made by inserting blunt-ended
AccIrPstI fragment of Gap1m cDNA into SmaI site
of pGEX4T-3.
The cDNA fragment corresponding to the amino
 .  .acids 1–122 PH or 1–181 PHqTH of mouse Tec
was subcloned into the pGEX vector to express the
GST-fusion protein of each region in Esherichia coli.
The fusion proteins were co-expressed with the groE
protein in E. coli, BL21, and were purified through
 .glutathione–Sepharose 4B column Pharmacia as
w xspecified by the supplier 24 .
3. Results
3.1. Purification of PIP binding proteins using PIP -3 3
APB
Recent studies show that PIP can interact with3
wproteins, such as Akt, PKC, PIP BP, and Btk 11,25–3
Fig. 5. Identification of the Tec tyrosine kinase as a PIP binding protein. Panel A. The cytosolic fractions were prepared from calf3
 .  .thymus and mixed with PIP -APB beads. The proteins bound to the beads conjugated with lane 2 or without lane 1 PIP -APB were3 3
separated by SDS-PAGE, and visualized by silver staining. The positions of molecular weight standards are shown at the left. The arrow
 .  .heads indicates the position of Tec. Panel B. The proteins bound to the beads conjugated with lane 2 or without lane 1 PIP -APB were3
separated by SDS-PAGE, transferred to a PVDF membrane, and immunoblotted with an anti-Tec serum. The position of Tec is indicated
by an arrow head. Panel C. The cytosolic fractions were prepared from COS-7 cells transfected with the expression vector for Tec lanes
.  .  .3 to 6 or with pSR a , a control vector lanes 1 and 2 . The proteins bound to the beads conjugated with lanes 2, 4, 5 and 6 or without
 .PIP -APB lanes 1 and 3 were separated by SDS-PAGE and immunoblotted with anti-Tec serum. Prior to mixing with PIP -APB beads,3 3
 .  .the cytosolic fraction was incubated with 8 mM of free PIP lane 5 or with 0.8 mM PIP lane 6 for 1 h.3 3
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x27 , but it is still elusive how these proteins work
after interaction with PIP . It is likely that there are3
other target proteins for PIP . To identify novel PIP3 3
binding proteins, we synthesized a PIP analogue3
 .PIP -APB, Fig. 1 and used it for the purification of3
PIP binding proteins.3
The lysate from bovine brain was incubated with
the beads. As shown in Fig. 2A, much wider spec-
trum of protein species bound to the resin bearing
PIP -APB than those bearing IP -APB, the latter of3 3
 .which lacks the glycerol group of PIP Fig. 2C . To3
identify the proteins which specifically bound PIP ,3
free PIP was added to the cell lysates at the concen-3
tration of 12 mM before the exposure to the analogue
beads. By the pretreatment, several bands disap-
peared, which suggest that these protein specifically
interacted with PIP as shown in Fig. 2B. Twelve3
mM of PI 4,5-P did not inhibit the binding of these2
proteins to PIP -APB, suggesting that the affinity of3
the proteins to PIP was higher than that to PI 4,5-P .3 2
 .One of these peptides, p55 Fig. 2B , was trans-
fered to the membrane and its partial amino acid
sequence was analyzed. The amino acid sequences of
p55-derived peptides were identical to those of Akt g
 .data not shown . Akt g is one of the proteins that
w xhas been shown to bind PIP and PI3,4-P 33 . Thus,3 2
this result indicates that this system is useful to
identify PIP binding proteins.3
3.2. Identification of Gap1m as a PIP binding pro-3
tein
As shown in Fig. 2B, peptides with a molecular
 .mass of 97 kD p97 was detected as a PIP binding3
Fig. 6. Specific binding of Tec to PI 3,4,5-P . The cytosolic3
fractions of the COS-7 cells transfected with the Tec-expression
vector were incubated with PIP or other inositol-containing3
compounds for 1 h prior to mixing with PIP -APB beads. The3
proteins bound to the beads were separated by SDS-PAGE and
immunoblotted with anti-Tec serum. Panel A. Samples from
 .COS-7 expressing Tec were pre-incubated with PS alone lane 2 ,
 .  .6 mM PIP with PS lane 3 , 60 mM PI with PS lane 4 or with3
 .no lipids lane 1 . Panel B. The lysates were pre-incubated with 6
 .  .  .mM PIP lane 2 , 6 mM PI 4-P lane 3 , 15 mM PI 4-P lane 43
 . or 60 mM PI 4-P lane 5 with PS as a carrier, or PS alone lane
.1 . Panel C. The lysates were pre-incubated with 15 mM PIP3
 .  .  .lane 2 , 6 mM PIP lane 3 , 15 mM PI 4,5-P lane 4 , 6 mM PI3 2
 .  .4,5-P lane 5 with PS, or PS alone lane 1 . Panel D. The2
 .lysates were pre-incubated with 6 mM PIP lane 2 , 6 mM IP3 4
 .  .  .lane 3 , 18 mM IP lane 4 , 30 mM IP lane 5 , or PS alone.4 4
 .lane 1 .
 .Fig. 7. The PH domain of Tec is required for the binding of PIP . Panel A. The wild type Tec Tec protein contains a PH, a TH, a Src3
 .  .homology 3 SH3 , a Src homology 2 SH2 and a kinase domains in this order from its N-terminus. Structures of the C-terminally
 .  .  .truncated mutants -SH2, -SH3 and -TH or the mutants lacking PH DPH or SH3 DSH3 domains are schematically shown. The
structure of recombinant Tec proteins expressed in E.coli as GST fusion proteins are also shown in the lower panel. Panel B. Lysates
 .  .from COS-7 cells transfected with the pTagCMVneo, a control vector lane 1 , or with the expression vectors for wild type Tec lane 2 ,
 .  .  .
-SH2 lane 3 , -SH3 lane 4 and -TH lane 5 mutants were mixed with PIP -APB beads. The proteins bound to the beads were separated3
by SDS-PAGE, and probed with the anti-Tec antibody. The positions of Tec mutants are indicated at the right. The endogenous Tec
protein is co-purified and detected in the all experiments. Panel C. Lysates from COS-7 cells transfected with the pSR a , a control vector
 .  .  .  .lane 1 , or with the expression vector for wild Tec lane 2 , DPH lane 3 , and DSH3 lane 4 were mixed with PIP -APB beads. The3
proteins bound to the beads were purified and blotted with an anti-Tec antibody. The positions of the wild type or the deletion mutants
 .were indicated by arrow heads. Panel D. Four mg of GST- THqPH purified through glutathione–Sepharose beads were mixed with
PIP -APB beads. The proteins bound to the beads were separated by SDS-PAGE and stained with Coomassie blue. Before mixing with3
 .  .  .  .the beads, proteins were incubated with PIP lane 2 , PI 4,5-P lane 3 and 4 , IP lanes 5 and 6 , or PS lane 1 at the concentration3 2 4
indicated in the figure. For lane 7 and 8, the GST-PH domain was mixed with PIP -APB, after pre-incubation with PS micells with lane3
.  .8 or without lane 7 PIP . The positions of GST-THqPH or GST-PH are indicated by an arrow head.3
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protein. Previous reports showed that Gap1m and
Gap1IP4BP, the molecular masses of which were 97
kD and 94 kD, respectively, bind inositol 1,3,4,5-te-
 .trakisphosphate IP , a compound analogous to PIP4 3
w x28,29 . This prompted us to test the possibility that
p97 is either Gap1m or Gap1IP4BP. As shown in Fig.
3A, anti Gap1m antibody clearly recognized p97 and
the band disappeared when the lysate was incubated
with 4 mM PIP before mixing with the beads. The3
result strongly suggests that Gap1m binds PIP . To3
further confirm this result, the same experiment was
performed using the cell lysate of COS-7 cells trans-
fected with a Gap1m expression vector. The myc-
tagged Gap1m bound PIP -APB, and the binding was3
inhibited by the pre-incubation of the lysate with
 .synthetic PIP Fig. 3B , indicating that p97 was3
Gap1m. To determine the binding site for PIP , vari-3
m  .ous deletion mutants of Gap1 Fig. 4A were ex-
pressed in E. coli as GST fusion proteins, purified
and tested for their ability to bind PIP -APB. As3
shown in Fig. 4B, the PH domain of Gap1m bound
PIP -APB, whereas those mutants lacking PH do-3
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main, GST-C2 or GST-C2qGRD, did not under the
condition in which the similar levels of the proteins
were present in the reactions. In addition, the interac-
tion between PH domain and PIP -APB was inhibited3
by PIP at the concentration of 4 mM but not by IP3 4
 .Fig. 4C . These results indicate that the PH domain
of Gap1m is the binding site for PIP .3
3.3. Identification of Tec as a PIP binding protein3
Using the PIP -APB affinity column, we surveyed3
cellular proteins that bound to PIP -APB in various3
tissues other than bovine brain. When the lysate from
bovine thymus was used, many proteins were de-
 .tected Fig. 5A and some of them disappeared when
the cell lysate was pre-incubated with synthetic PIP3
before applying to PIP -APB affinity column data3
.not shown . The set of PIP binding proteins detected3
by competition with PIP from the bovine thymus3
was quite different from that detected from the brain
suggesting that the role of PI3-kinase may differ
among the tissues. One of such bands had a molecu-
lar mass of 70 kD, which was close to that of Tec, a
member of Btk tyrosine kinase family. Because Btk
is known to bind PIP , we tested whether this 70 kDa3
protein is Tec or not. As shown in Fig. 5B, the 70
kDa protein was detected by the anti-Tec antibody,
suggesting that Tec could also bind PIP .3
Tec protein expressed in COS-7 cells also bound
to PIP -APB, as shown in Fig. 5C. This binding was3
abolished by the presence of free synthetic PIP .3
These results suggest that Tec binds PIP .3
3.4. Tec specifically binds PIP through the PH3
domain
Recent reports have shown that the PH domain of
Btk binds PIP and IP , and that PIP has higher3 4 3
affinity to Btk PH than IP , suggesting that PIP is4 3
w xthe physiological ligand for Btk PH 30 . We there-
fore examined the relative affinities of PS, PI, PI 4-P,
PI 4,5-P , and IP to the PH domain of Tec, by2 4
measuring their ability to compete with PIP -APB.3
As shown in Fig. 6, the binding of Tec to PIP -APB3
was inhibited by PIP at 6 mM, whereas PI 4,5-P3 2
and PI 4-P needed higher concentration to inhibit this
 .interaction 15 mM and 60 mM, respectively . PI and
IP did not show any inhibitory effects even at 604
mM and 30 mM, respectively. These results suggest
that Tec binds PIP with the highest affinity among3
these PIP -related compounds. To determine the bind-3
ing site for PIP , various deletion mutants of Tec3
 .Fig. 7A were expressed in COS-7 cells and their
binding capacities to PIP -APB were analyzed. Trun-3
cation of carboxy terminus did not abolish PIP -APB3
binding as long as PH domain were preserved Fig.
.7B . On the other hand, a Tec mutant lacking PH
 .domain DPH did not bind PIP -APB, while another3
 .  .deletion mutant DSH3 did Fig. 7C . These results
demonstrate that PH domain is critical for PIP -Tec3
interaction. Moreover, two Tec deletion mutants con-
taining PH domain expressed as GST fusion proteins
 .in E. coli GST-PHqTH and GST-PH, Fig. 7A
bound PIP -APB and these interactions were inhib-3
ited by the addition of the synthetic PIP at the3
 .concentration of 8 mM Fig. 7D , whereas the addi-
 .  .tion of PI 4,5-P 16 mM or IP 24 mM did not2 4
affect the binding. Similar results were also obtained
 .with GST-PH data not shown . These results indi-
cate that PIP specifically binds Tec through the PH3
domain.
4. Discussion
In this study, we have demonstrated that PIP -APB3
is very useful to purify and identify PIP binding3
proteins and revealed that Gap1m and Tec tyrosine
kinase are the novel PIP binding proteins.3
A newly designed PIP analogue, PIP -APB,3 3
showed higher affinity and specificity than IP -APB,3
 .since proteins such as p70, p55 Aktg , and p53,
which were not detected by IP -APB, were obtained3
 .by a single step from a cell lysate Fig. 2A . There-
fore, it is highly likely that PIP binding proteins3
recognize not only the head group but also the glyc-
erol group of PIP , and that PIP and IP may be3 3 4
recognized as distinct substances. Our recent result
indicates that long saturated fatty acids on the 2X
position of the glycerol group blocks the reaction of
PI3-kinase and PIP phosphatase while shorter fatty3
acids do not Nakatsu et al. manuscript in prepara-
.tion . This observation suggests that whole structure
of the lipid sometimes affect the reactivity of the
head group. Our PIP analogue, PIP -APB, which3 3
contains a glycerol group and short fatty acids in the
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2X position, was designed based on such information
to detect target proteins of PIP with higher speci-3
ficity. One may argue that such an analogue may be
degraded by PIP phosphatases, however, the ana-3
logue was stable in the cell lysate for unknown
reason and reusable many times. The pattern of bind-
ing proteins was virtually the same every time, sug-
gesting that the PIP -APB was stable during the3
incubation. Using PIP -APB affinity resin, we found3
that Tec and Gap1m bind PIP and that the binding3
sites for PIP reside within the PH domains, which3
have been shown to bind phospholipids to regulate
enzymatic activity or membrane localization.
Gap1m was purified as a Ras GTPase activating
protein and its PH domain was recently shown to
w x mbind IP 28,31 . Our result showed that Gap1 bound4
PIP , raising an intriguing possibility that PIP is the3 3
preferable ligand for Gap1m PH domain, since the
interaction between Gap1m and PIP -APB was inhib-3
ited by PIP and not by IP . In addition, Gap1IP4BP,3 4
another Ras GTPase activating protein also bearing a
PH domain, which had been shown to bind IP , also4
bound PIP -APB beads and the binding was com-3
peted by the free PIP , indicating that Gap1IP4BP is3
 .another PIP binding protein data not shown . It3
should be noted that p110 subunit of PI3-kinase was
known to bind Ras, which results in the activation of
w xits lipid kinase activity 32 , suggesting that there
may be some interaction between Ras and PI3-kinase
pathways. Our results may provide an new insight
into the Ras-PI3-kinase signaling pathway, however,
it is still an open question how PIP or IP function in3 4
intact cells through the interaction with Gap1m.
The binding of Tec to PIP was highly specific.3
The binding affinity of phospholipids for Tec PH
was: PIP )PI4,5-P )PI4-P4PI, PS. IP did not3 2 4
inhibit PIP -Tec PH binding at the concentration up3
to 30 mM. It has been reported that the PH domain of
Btk, a related tyrosine kinase of Tec, binds IP or4
w xPIP 30 . Our data shows that Tec also binds PIP3 3
and binding site is located in the PH domain. Inabil-
ity of IP to compete out PIP -APB might be due to4 3
the large difference between the affinities of PIP and3
IP . Thus, our observation supports the idea that PIP4 3
is a preferable binding partner for Tec-PH. To exam-
ine the biological significance of the binding of Tec
to PIP , we have tested whether co-expression of3
PI3-kinase could affect the tyrosine kinase activity of
Tec. Co-expression of constitutively active PI3-kinase
did not activate but rather inhibited the kinase activ-
 .ity of Tec to a small extent data not shown . In
contrast, however, our preliminary result suggest that
PI3-kinase may be activated by Tec. Further study is
required to understand how PI3-kinase and Tec is
interacting in intact cells.
In this study we have identified Tec and Gap1m as
novel PIP binding proteins. However, there still3
remain many unidentified PIP binding proteins. Our3
newly developed system may be a quite useful and
powerful tool for such a study.
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